Evoq Remedies Limited Share Price

Evoq Remedies Limited Share Price

BSE: 543500
|
Trading
|
S Cap
₹ 1.82
+0.00 (0.00%)
1D
Last updated 13 Aug, 2026, 15:27 IST

--
0.00% up today
--
1D LOW
1D HIGH

Evoq Remedies Limited Returns Calculator


Circuit
L
H
₹1.73
₹1.91
52-week
L
H
₹1.63
₹6.11

About Evoq Remedies Limited

Evoq Remedies Limited Share Price
ISIN
INE0JVD01011
Sector Market Cap
₹ 4.53 Cr

EVOQ Remedies Limited is an India-based pharmaceutical company. The Company is engaged in the pharmaceutical business involving marketing, trading, and distribution of a range of pharmaceutical formulation products, such as antibiotic drugs, anti-malarial drugs, anti-allergic and cold drugs, analgesic/antipyretic and anti-inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastrointestinal drugs, steroids, gynecology drugs, calcium, multivitamins, antioxidants, and injections. It offers a range of pharmaceutical formulation products, of which around 120 products are marketed by the Company under its own brand name. The Company also deals in the trading of active pharmaceutical ingredients (APIs). Its products include Abacavir Sulfate, Acetazolamide, Acyclovir, Adefovir Dipivoxil Allylestrenole, Alpha Beta Arteether, Alpha Lipoic Acid, Alprazolam, Amoxycillin Trihydrate, Ampicillin Trihydrate, Artemether, Finasteride, Imipramine, Lidocaine, and more.

Evoq Remedies Limited Financial Highlights

  • Revenue: Evoq Remedies Limited reported revenue of ₹26.76 crore in FY26 vs ₹14.17 crore in FY25. It showed an increase of 88.85% on a yearly basis.
  • Operating Profit: Evoq Remedies Limited reported an operating loss of ₹0.25 crore in FY26 vs ₹0.13 crore in FY25. It showed a decrease of 292.31% on a year-on-year basis.
  • Net Profit: Evoq Remedies Limited reported a net loss of ₹0.24 crore in FY26 vs ₹0.09 crore in FY25. It showed a decrease of 366.67% on a yearly basis.
Know more
Promoters
0.02%
FII
0.00%
Other DII
0.00%
Retail and other
99.98%
Mutual funds
0.00%
Foreign institutions - FII
FII shareholding by period
Sep 20240.00%
Mar 20250.00%
Sep 20250.00%
Mar 20260.00%
Mkt Cap Cr
4.53

P/E
-18.50

P/B
0.10

ROE
-0.54%

D/E
0.00

ROCE
-0.57%

Div. Yield
0.00%

EPS(TTM)
-0.10
Turnover
0.58

EV/EBITDA
0.00

Net Margin
0.00%

Op. Margin
0.00%

ROA
0.00%

Quick Ratio
0.00

Curr. Ratio
6.84
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Evoq Remedies has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Evoq Remedies appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
ADANI ENTERPRISES4,00,060.0053.684.263.93%0.185.11%574.690.04%0.2893.20
PREMIER ENERGIES LIMITED46,802.4027.9610.8635.05%0.3126.37%42.630.02%0.283.19
Aegis Logistics44,382.2029.677.2314.83%0.1215.38%98.560.70%0.8726.88
Redington27,022.0017.652.6114.67%0.2815.80%67.831.77%4.1015.91
HONASA CONSUMER LIMITED15,254.7078.0311.0614.16%0.0817.48%42.840.62%1.155.86
LLOYDS ENTERPRISES LTD11,839.3041.602.806.84%0.0910.45%34.100.19%0.061.98
MMTC9,582.0021.444.524.72%0.007.79%11.330.00%0.001.41
SG MART LIMITED9,041.7772.765.666.96%0.0110.42%122.330.00%2.937.01
GNG ELECTRONICS LIMITED6,532.2945.808.6117.42%0.2815.97%44.260.00%1.453.50
Arvind Fashions6,011.8931.796.2812.99%0.1018.06%174.180.36%0.260.10

Evoq Remedies Limited Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹11.76₹4.05₹20.39₹16.78
Other Income₹2.41₹2.26₹6.02₹0.00
Total Revenue₹14.17₹6.31₹26.41₹16.78
Total Expenses₹14.04₹5.70₹24.13₹15.32
Profit Before Tax₹0.13₹0.61₹2.28₹1.46
Tax₹0.04₹0.16₹0.67₹0.37
Profit After Tax₹0.09₹0.45₹1.62₹1.09
EPS - Basic₹0.04₹0.33₹1.19₹0.70
EPS - Diluted₹0.04₹0.33₹1.19₹0.70

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹0.13₹0.61₹2.28₹1.46
Income before WC changes₹0.18₹0.62₹2.29₹1.46
Change in Assets-₹12.85-₹2.08-₹4.50-₹22.22
Change in Liabilities-₹1.91₹6.94-₹1.47-₹5.30
Change in WC-₹14.76₹4.86-₹5.97-₹27.52
Cash flow from Operations-₹14.62₹5.32-₹4.35-₹26.43
Cash flow from Investing-₹0.26-₹0.01-₹0.01₹0.00
Cash flow from Financing₹14.97-₹5.34₹1.42₹29.49
Total Cash Flow₹0.09-₹0.03-₹2.94₹3.06
Cash (Start of the year)₹0.12₹0.15₹3.09₹0.03
Cash (End of the year)₹0.21₹0.12₹0.15₹3.09

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹0.22₹0.01₹0.01₹0.00
Current Assets₹49.79₹36.85₹34.89₹33.33
Total Assets₹50.01₹36.86₹34.90₹33.33
Current Liabilities₹5.47₹11.62₹10.11₹10.17
Net Current Asset₹44.31₹25.22₹24.78₹23.17
Non-Current Liabilities₹0.00₹0.00₹0.00₹0.00
Equity Capital₹44.54₹25.24₹24.79₹23.17
Total Equity & Liabilities₹50.01₹36.86₹34.90₹33.33
* All values are in INR Crore
Qty
Bid
4000
1.8
12000
1.73
0
0
0
0
0
0
Ask
Qty
1.88
4000
1.89
4000
1.9
4000
0
0
0
0
Bid Total: 16000
Ask Total: 12000
Buy orders: 57%
Sell orders: 43%
Bearish
2
Neutral
6
Bullish
0
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict

RSI (14)
37.55
Neutral

ATR (14)
0.08
Neutral

STOCH(9,6)
53.57
Neutral

STOCH RSI (14)
73.88
Neutral

ADX(9)
31.26
Bearish

UO(9)
60.57
Neutral

ROC(12)
-1.09
Bearish

WillR(14)
-40.62
Neutral
Period
Simple value
Exponential vaue

5D
1.85
1.84

10D
1.82
1.84

20D
1.86
1.91

50D
2.25
2.23

100D
2.73
2.53
Volume trend — traded volume by day
13 Aug0L
12 Aug0L
11 Aug0L
10 Aug0L
7 Aug0L
Average0L
Compare against other stocks
Evoq Remedies Limited Share Price
Evoq Remedies Limited
Trading
Add Stock
Add Another

Evoq Remedies Limited Share Price FAQs